skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

Neuropsychiatric Disease and Treatment

(2,361,229) Views

Editor in Chief Dr Roger M Pinder

1176-6328

Case report
Errorless learning and spaced retrieval techniques to relearn instrumental activities of daily living in mild Alzheimer’s disease: A case report study
Stéphanie Thivierge, Martine Simard, Léonie Jean, Éric Grandmaison
Neuropsychiatric Disease and Treatment 2008, 4:987-999
07 August 2008

Original Research
Validity and reliability of the Structured Clinical Interview for Depersonalization–Derealization Spectrum (SCI-DER)
Marco Mula, Stefano Pini, Simona Calugi, Matteo Preve, Matteo Masini, et al
Neuropsychiatric Disease and Treatment 2008, 4:977-986
29 August 2008

Original Research
An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia
Giorgio L Colombo, Mauro Caruggi, Sergio Di Matteo, Alessandro Rossi
Neuropsychiatric Disease and Treatment 2008, 4:967-976
28 August 2008

Original Research
The efficacy of mirtazapine in agitated patients with Alzheimer’s disease: A 12-week open-label pilot study
Sibel Cakir, Isin Baral Kulaksizoglu
Neuropsychiatric Disease and Treatment 2008, 4:963-966
22 September 2008

Rapid Communication
Five personality dimensions in patients with irritable bowel syndrome
Alireza Farnam, Mohammad H Somi, Firouz Sarami, Sara Farhang
Neuropsychiatric Disease and Treatment 2008, 4:959-962
08 August 2008

Original Research
Direct and indirect effects of paliperidone extended-release tablets on negative symptoms of schizophrenia
Ibrahim Turkoz, Cynthia A Bossie, Bryan Dirks, Carla M Canuso
Neuropsychiatric Disease and Treatment 2008, 4:949-958
26 August 2008

Review
Augmentation treatment in major depressive disorder: focus on aripiprazole
J Craig Nelson, Andrei Pikalov, Robert M Berman
Neuropsychiatric Disease and Treatment 2008, 4:937-948
11 August 2008

Review
The role of duloxetine in the treatment of anxiety disorders
Domenico De Berardis, Nicola Serroni, Alessandro Carano, Marco Scali, Alessandro Valchera, et al
Neuropsychiatric Disease and Treatment 2008, 4:929-935
25 July 2008

Review
Risperidone long-acting injection: a review of its long term safety and efficacy
Michael K Rainer
Neuropsychiatric Disease and Treatment 2008, 4:919-927
26 August 2008

Review
Attention-deficit-hyperactivity disorder and reward deficiency syndrome
Kenneth Blum, Amanda Lih-Chuan Chen, Eric R Braverman, David E Comings, Thomas JH Chen, et al
Neuropsychiatric Disease and Treatment 2008, 4:893-917
11 November 2008

Review
Traumatic brain injury: future assessment tools and treatment prospects
Steven R Flanagan, Joshua B Cantor, Teresa A Ashman
Neuropsychiatric Disease and Treatment 2008, 4:877-892
12 October 2008

Review
Inflammation as a potential mediator for the association between periodontal disease and Alzheimer’s disease
Amber Watts, Eileen M Crimmins, Margaret Gatz
Neuropsychiatric Disease and Treatment 2008, 4:865-876
10 September 2008

Review
Brain ischemia and ischemic blood–brain barrier as etiological factors in sporadic Alzheimer’s disease
Ryszard Pluta, Marzena Utamek, Poland
Neuropsychiatric Disease and Treatment 2008, 4:855-864
26 August 2008

Review
Cannabinoids in the management of spasticity associated with multiple sclerosis
Anna Maria Malfitano, Maria Chiara Proto, Maurizio Bifulco
Neuropsychiatric Disease and Treatment 2008, 4:847-853
29 August 2008

Review
Potential cellular and regenerative approaches for the treatment of Parkinson’s disease
Emma L Lane, Olivia J Handley, Anne E Rosser, Stephen B Dunnett
Neuropsychiatric Disease and Treatment 2008, 4:835-845
26 August 2008

Perspectives
Intrathecal corticosteroids might slow Alzheimer’s disease progression
Joseph Martin Alisky
Neuropsychiatric Disease and Treatment 2008, 4:831-833
02 September 2008